Full HTML: REFERENCES
1. Erkkinen MG, Kim M, Geschwind MD. Major Neurodegenerative Diseases. 2018; Doi:10.1101/cshperspect.a033118
2. Pradeep S, Jain AS, Dharmashekara C, Prasad SK, Kollur SP, Syed A, et al. Alzheimer’s Disease and Herbal Combination Therapy: A Comprehensive Review. Journal of Alzheimer’s Disease Reports. 2020;4(1):417–29.
3. Kamran M, Kousar R, Ullah S, Khan S, Umer MF, Rashid HU, et al. Taxonomic Distribution of Medicinal Plants for Alzheimer’s Disease: A Cue to Novel Drugs. International Journal of Alzheimer’s Disease. 2020;2020.
4. Cummings J, Aisen PS, Dubois B, Frölich L, Jack CR, Jones RW, et al. Drug development in Alzheimer’s disease: The path to 2025. Alzheimer’s Research and Therapy. 2016;8(1):1–19.
5. Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et al. Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria. Vol. 12, Alzheimer’s and Dementia. 2016. 292–323.
6. Patil DT, Singh A, Kanase V. A Review On Causes , Stages And Treatments Used In Alzheimer ’ S Disease. 2017;6(12):251–67.
7. Pandey MM, Rastogi S, Rawat AKS. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evidence-based Complementary and Alternative Medicine. 2013;2013.
8. Rao R v., Descamps O, John V, Bredesen DE. Ayurvedic medicinal plants for Alzheimer’s disease: A review. Alzheimer’s Research and Therapy. 2012;4(3):1–9.
9. Farooqui AA, Farooqui T, Madan A, Ong JHJ, Ong WY. Ayurvedic Medicine for the Treatment of Dementia: Mechanistic Aspects. Evidence-based Complementary and Alternative Medicine. 2018;2018.
10. Akram M, Nawaz A. Effects of medicinal plants on alzheimer’s disease and memory deficits. Neural Regeneration Research. 2017;12(4):660–70.
11. Ali SK, Hamed AR, Soltan MM, Hegazy UM, Elgorashi EE, El-Garf IA, et al. In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of alzheimer disease. BMC Complementary and Alternative Medicine [Internet]. 2013;13(1):1. Available from: BMC Complementary and Alternative Medicine
12. Anlauf M, Hein L, Hense HW, Köbberling J, Lasek R, Leidl R, et al. Complementary and alternative drug therapy versus science-oriented medicine. GMS German Medical Science. 2015;13:1–47.
13. Geun Kim H, Sook Oh M. Herbal Medicines for the Prevention and Treatment of Alzheimer’s Disease. Current Pharmaceutical Design. 2012;18(1):57–75.
14. Sharma R, Kuca K, Nepovimova E, Kabra A, Rao MM, Prajapati PK. Traditional Ayurvedic and herbal remedies for Alzheimer’s disease: from bench to bedside. Expert Review of Neurotherapeutics [Internet]. 2019;19(5):359–74. Available from: https://doi.org/10.1080/14737175.2019.1596803
15. Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics. 2019;16(3):666–74.
16. Chaudhari KS, Tiwari NR, Tiwari RR, Sharma RS. Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer’s disease. Annals of Neurosciences. 2017;24(2):111–22.
17. Bihaqi SW, Singh AP, Tiwari M. In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats. Indian Journal of Pharmacology. 2011;43(5):520–5.
18. Khare P, Chaudhary S, Singh L, Yadav G, Verma S. Evaluation of Nootropic activity of Cressa cretica in scopola-mine- induced memory impairment in mice. International Journal of Pharmacology and Toxicology. 2014;2(2).
19. Malik J, Karan M, Dogra R. Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: Possible antioxidant mechanism. Pharmaceutical Biology [Internet]. 2017;55(1):980–90. Available from: http://dx.doi.org/10.1080/13880209.2017.1285945
20. Sahab Uddin Md. Evaluation of Nootropic Activity of Persicaria flaccida on Cognitive Performance, Brain Antioxidant Markers and Acetylcholinesterase Activity in Rats: Implication for the Management of Alzheimer’s Disease. American Journal of Psychiatry and Neuroscience. 2016;4(2):26.
21. Sujith K, Darwin CR, Sathish, Suba V. Memory-enhancing activity of Anacyclus pyrethrum in albino Wistar rats. Asian Pacific Journal of Tropical Disease. 2012;2(4):307–11.
22. Howes MJR, Perry NSL, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders. Phytotherapy Research. 2003;17(1):1–18.
23. Wu TY, Chen CP, Jinn TR. Traditional Chinese medicines and Alzheimer’s disease. Taiwanese Journal of Obstetrics and Gynecology [Internet]. 2011;50(2):131–5. Available from: http://dx.doi.org/10.1016/j.tjog.2011.04.004
24. Sun ZK, Yang HQ, Chen S di. Traditional Chinese medicine: A promising candidate for the treatment of Alzheimer’s disease. Translational Neurodegeneration. 2013;2(1):1–7.
25. Howes MJR, Fang R, Houghton PJ. Effect of Chinese Herbal Medicine on Alzheimer’s Disease [Internet]. 1st ed. Vol. 135, International Review of Neurobiology. Elsevier Inc.; 2017. 29–56. Available from: http://dx.doi.org/10.1016/bs.irn.2017.02.003
26. Iranshahy M, Javadi B. Diet therapy for the treatment of Alzheimer’s disease in view of traditional Persian medicine: A review. Iranian Journal of Basic Medical Sciences. 2019;22(10):1102–17.
27. Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, et al. Clinical trials and late-stage drug development for Alzheimer’s disease: An appraisal from 1984 to 2014. Journal of Internal Medicine. 2014;275(3):251–83.
28. Pi R, Mao X, Chao X, Cheng Z, Liu M, Duan X, et al. Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-β-mediated Alzheimer’s disease-associated pathogenesis in vitro and in vivo. PLoS ONE. 2012;7(2):1–8.
29. Govind N. Donepezil for dementia due to Alzheimer’s disease. British Journal of Community Nursing. 2020;25(3):148–9.
30. by Dove Press published. CIA-129145-role-of-rivastigmine-in-subcortical-vascular-dementia-and-pa. 2017;697–707. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402908/pdf/cia-12-697.pdf
31. Russo P, Frustaci A, del Bufalo A, Fini M, Cesario A. From Traditional European Medicine to Discovery of New Drug Candidates for the Treatment of Dementia and Alzheimer's Disease: Acetylcholinesterase Inhibitors. Current Medicinal Chemistry. 2013;20(8):976–83.
32. Yang G, Wang Y, Tian J, Liu JP. Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. PLoS ONE. 2013;8(9).
33. Folch J, Busquets O, Ettcheto M, Sánchez-López E, Castro-Torres RD, Verdaguer E, et al. Memantine for the treatment of dementia: A review on its current and future applications. Journal of Alzheimer’s Disease. 2018;62(3):1223–40.
34. Teixeira JP, de Castro AA, Soares F v., da Cunha EFF, Ramalho TC. Future therapeutic perspectives into the Alzheimer’s disease targeting the oxidative stress hypothesis. Molecules. 2019;24(23):1–17.
35. Ellison JM. What’s New in the Alzheimer’s Treatment Pipeline? 2020;1-7
|